Nuvation Bio Inc. reported condensed earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $20,434,000 against $9,017,000 a year ago. Net loss was $19,333,000 against $8,599,000 a year ago. Basic and diluted net loss per share attributable to common stockholders was $0.09 against $0.10 a year ago. For the six months, the company reported loss from operations of $40,918,000 against $18,237,000 a year ago. Net loss was $39,735,000 against $17,345,000 a year ago. Basic and diluted net loss per share attributable to common stockholders was $0.21 against $0.20 a year ago.